Padyana Mahesha, Karanth Sunil, Vaidya Shriram, Gopaldas Justin Aryabhat
Department of Critical Care Medicine, Manipal Hospital, Bengaluru, Karnataka, India.
Indian J Crit Care Med. 2019 Jun;23(6):270-273. doi: 10.5005/jp-journals-10071-23178.
India is one of the seven identified countries in South-East Asia region regularly reporting dengue fever (DF)/dengue hemorrhagic fever (DHF) outbreaks. Even though the dengue prodrome and evolution of illness are most often similar in many patients, progress and outcome may differ significantly depending on the severity of illness as well as treatment instituted. We studied the clinical manifestations, outcome and factors predicting mortality of serology confirmed dengue fever cases admitted in Multidisciplinary Intensive Care Unit (MICU) of a high acuity healthcare facility in India.
All patients with serology proven dengue fever admitted to MICU between 1st July 2015 and1st December 2015 were included in the study. Clinical presentation, laboratory findings, severity of illness scores and outcome were recorded.
Majority of the patients (58.4%) belonged to 21-40 year age group. Hepatic (96.8%) followed by hematological (79.2%) involvement were the most common findings. CNS involvement observed among 27%. Survival to hospital discharge was 78.9%. Respiratory and gastrointestinal system involvement was associated with increased mortality. Acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and shock were the clinical syndromes associated with mortality. Serum lactate, aspartate transaminase (AST) and alanine transaminase (ALT) were significantly elevated among non survivors. Significant difference in sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation (APACHE) scores was also observed among survivors and non survivors.
Organ system involvement and higher disease severity scores are strong predictors of mortality. High index of suspicion for atypical manifestations of dengue is warranted.
Padyana M, Karanth S, Vaidya S, Gopaldas JA. Clinical Profile and Outcome of Dengue Fever in Multidisciplinary Intensive Care Unit of a Tertiary Level Hospital in India. Indian J Crit Care Med 2019;23(6):270-273.
印度是东南亚地区定期报告登革热(DF)/登革出血热(DHF)疫情的七个已确定国家之一。尽管许多患者的登革热前驱症状和疾病演变通常相似,但病情进展和结局可能因疾病严重程度以及所采取的治疗措施而有显著差异。我们研究了在印度一家高 acuity 医疗机构的多学科重症监护病房(MICU)收治的血清学确诊登革热病例的临床表现、结局及预测死亡的因素。
纳入 2015 年 7 月 1 日至 2015 年 12 月 1 日期间入住 MICU 的所有血清学确诊登革热患者。记录临床表现、实验室检查结果、疾病严重程度评分及结局。
大多数患者(58.4%)年龄在 21 - 40 岁组。最常见的表现是肝脏受累(96.8%),其次是血液系统受累(79.2%)。27%的患者观察到中枢神经系统受累。出院存活率为 78.9%。呼吸和胃肠道系统受累与死亡率增加相关。急性呼吸窘迫综合征(ARDS)、急性肾损伤(AKI)和休克是与死亡相关的临床综合征。非幸存者的血清乳酸、天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)显著升高。幸存者和非幸存者之间在序贯器官衰竭评估(SOFA)和急性生理与慢性健康评估(APACHE)评分上也观察到显著差异。
器官系统受累和更高的疾病严重程度评分是死亡的有力预测因素。对登革热非典型表现保持高度怀疑是必要的。
帕迪亚纳 M,卡兰思 S,瓦伊迪亚 S,戈帕尔达斯 JA。印度三级医院多学科重症监护病房登革热的临床特征与结局。《印度危重症医学杂志》2019;23(6):270 - 273。